Ontology highlight
ABSTRACT: Objective
To investigate injection site pain (ISP) and other injection site outcomes caused by biologics administered alongside citrate-free (CF) and citrate-containing (CC) formulations.Methods
Electronic literature databases (Medline, Embase, and Cochrane Library) were systematically searched for clinical trials and observational studies reporting on injection site outcomes after subcutaneous administration of biologics. Studies with unknown excipient formulations were excluded. The primary outcome was ISP, and secondary outcomes included any other reported injection site reactions (ISRs). Meta-analysis approaches were used to aggregate evidence identified via the conducted systematic literature review.Results
A total of two observational studies, two cross-over/s
SUBMITTER: Junker S
PROVIDER: S-EPMC10433360 | biostudies-literature | 2023 Jun
REPOSITORIES: biostudies-literature